Market Concerns Amid High Valuations

Victoria Fernandez, Chief Market Strategist at Crossmark Global Investments, cautions that stretched market valuations and interest rate worries are creating volatility.

Biotech Sector Insights

Fernandez identifies Gilead as a promising investment, highlighting its potential as the biotech sector shows signs of recovery.